Financial results - TAKEDA PHARMACEUTICALS SRL

Identification data, financial results - Takeda Pharmaceuticals Srl

Unique identification code: 18138597
Registration number: J40/19332/2005
CAEN: 4646
Sales - Ron
60.260.056
Net Profit - Ron
2.486.807
Employee
47
For a more advanced analysis and a comparison with the industry the company belongs to, open a customer account and view the financial reports: Financial Rating, Payment Limits, Probability of Insolvency, Market Share or Competition.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Takeda Pharmaceuticals Srl

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Sales - EUR 20.164.148 16.730.288 21.606.348 26.572.759 26.436.353 23.472.858 26.261.313 45.763.568 52.013.092 60.260.056
Total Income - EUR 20.291.976 16.800.926 21.658.201 26.586.497 26.643.410 23.512.516 26.280.148 45.771.573 52.017.215 60.298.442
Total Expenses - EUR 20.099.500 17.142.884 20.820.910 24.833.869 27.618.412 22.242.297 25.386.506 44.484.551 49.146.014 57.129.033
Gross Profit/Loss - EUR 192.476 -341.958 837.291 1.752.628 -975.002 1.270.219 893.642 1.287.022 2.871.201 3.169.409
Net Profit/Loss - EUR 134.688 -401.168 896.995 1.752.628 -1.101.445 1.167.580 750.369 1.137.616 2.622.284 2.486.807
Employees 33 24 18 18 20 23 25 40 44 47
Check the financial evolution reflected in Turnover, Profit, number of employees, companies' debts over the last 10 years and make informed business decisions.

Check the financial reports for the company - Takeda Pharmaceuticals Srl

Rating financiar

Financial Rating -
Takeda Pharmaceuticals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Takeda Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Takeda Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Takeda Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports

Debts, Equity, Inventories, Receivables, Accounts, Assets - Takeda Pharmaceuticals Srl - CUI 18138597

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Fixed Assets 49.086 30.643 31.491 34.796 113.112 104.262 291.580 716.524 575.757 389.614
Current Assets 27.908.022 22.527.957 17.066.194 20.550.424 18.596.441 16.358.366 24.271.439 37.490.826 36.669.373 46.140.023
Inventories 4.578.618 4.168.019 2.390.939 3.929.083 4.896.575 3.645.485 3.558.164 11.885.711 6.761.410 8.331.510
Receivables 21.661.184 15.591.900 13.310.587 12.159.550 10.400.634 11.002.098 13.923.161 22.519.230 25.914.823 34.290.759
House and accounts 1.668.220 2.768.039 1.364.668 4.461.792 3.299.232 1.710.783 6.790.114 3.085.885 3.993.140 3.517.754
Own Capitals 1.221.508 820.009 1.213.545 2.953.797 1.802.369 2.936.872 3.630.366 5.706.135 18.309.424 20.790.561
Social Capital 780 781 787 779 766 752 738 897 10.108.422 10.139.783
Liability 26.749.383 21.752.558 15.902.175 17.679.370 16.945.084 13.547.860 20.945.278 32.545.887 18.968.746 25.799.022
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821 4.4847
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
Search for any company and analyze the financial data as well as the indicators generated based on them.
For a more advanced analysis and a comparison with the industry the company belongs to, open a customer account and view the financial reports: Financial Rating, Payment Limits, Probability of Insolvency, Market Share or Competition.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Reports that can be accessed based on the subscription:

  • Financial Rating
  • Payment Limits
  • Outstanding Debts
  • Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.

Reviews - Takeda Pharmaceuticals Srl

Comments - Takeda Pharmaceuticals Srl